AIIC
RNTX

AJU IB Investment Company’s Rein Therapeutics RNTX Stock Holding History

AJU IB Investment Company’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,878
Closed -$528K – 11
2021
Q3 		$528K Hold
25,878
– – 0.34% 10
2021
Q2 		$647K Hold
25,878
– – 0.37% 10
2021
Q1 		$740K Hold
25,878
– – 0.28% 10
2020
Q4 		$538K Buy
+25,878
New +$647K 0.2% 10

Other funds holding RNTX

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

AJU IB Investment Company's RNTX Position: Q4 2021 in Review

AJU IB Investment Company sold out of Rein Therapeutics (RNTX) in Q4 2021, closing a stake of 25,878 shares — an estimated $528K sold.

AJU IB Investment Company first reported a position in RNTX in Q4 2020 and held it in 4 quarters. The position peaked at $740K in Q1 2021. 43 funds tracked by Wall St. Rank hold RNTX as of Q4 2021.

  • AJU IB Investment Company reported no remaining Rein Therapeutics position as of Q4 2021 after selling out during the quarter.
  • AJU IB Investment Company sold 25,878 Rein Therapeutics shares in Q4 2021, an estimated $528K.
  • AJU IB Investment Company first reported a position in Rein Therapeutics in Q4 2020 and held it in 4 quarters.
  • AJU IB Investment Company's Rein Therapeutics position peaked at $740K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Rein Therapeutics as of Q4 2021.

Based on AJU IB Investment Company's 13F filing for Q4 2021, filed 9 Feb 2022.